"The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
AMINOCAPROIC ACID - ORAL
COMMON BRAND NAME(S): Amicar
USES: This medication is used to treat severe bleeding caused by problems with the blood clotting system, which helps you to stop bleeding. Aminocaproic acid works by affecting the blood clotting system, thereby slowing/stopping bleeding after surgery, in some bleeding conditions, or in severe liver disease.
HOW TO USE: Take this medication by mouth exactly as directed by your doctor. It is important to take each dose at the correct time for this medication to be most effective. Do not skip any doses or take this medication more often than prescribed.
If you are using the liquid form of this medication, measure your dose with a special measuring spoon or device. Do not use a household spoon because it may not provide the correct dose.
Dosage is based on your medical condition and response to therapy.
Inform your doctor if your condition persists or worsens.
Additional Amicar Information
Amicar - User Reviews
Amicar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.